Crucial functionalizations of carbon nanotubes for improved drug delivery: a valuable option?

Pharmaceutical Research
Giorgia Pastorin

Abstract

Amidst the myriad of drug delivery systems able to enhance delivery, absorption and intracellular uptake of a bioactive molecule while protecting it from deactivation, Carbon Nanotubes (CNTs) have emerged as a recent and promising option especially in cancer therapy. This is mainly due to their unique properties, which render them extremely versatile through the incorporation of several functional groups and targeting molecules at the same time, while their natural shape allows them to selectively penetrate across biological barriers in a non-invasive way. In this expert review we aim to evaluate whether this innovative material, once chemically-modified with suitable functionalizations, can be considered as a valuable system in comparison to the already existing nanodevices. This will include the estimation of the most recent advances in the field of nanotechnology, together with a cautious evaluation of potential risks and hazards associated with the extensive use of this fascinating, but still unknown, nanomaterial.

References

Jun 1, 1976·Annals of the Rheumatic Diseases·A E FinkelsteinA Misher
Jan 1, 1983·Scandinavian Journal of Rheumatology. Supplement·J Petersen, K Bendtzen
Jan 1, 1994·Acta Oncologica·A GabizonT Peretz
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M A JordanL Wilson
May 18, 1999·Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·J F Hillyer, R M Albrecht
Jul 15, 1992·Physical Review. B, Condensed Matter·R SaitoM S Dresselhaus
Mar 22, 2001·Advanced Drug Delivery Reviews·C W Pouton, L W Seymour
Jul 18, 2001·Journal of the American Chemical Society·R J ChenH Dai
Jul 27, 2001·Nature·S Fernandez-LopezM R Ghadiri
Feb 19, 2002·Chemical Reviews·P. M. Ajayan
Jun 22, 2002·Science·Sang Bok LeeCharles R Martin
Jul 27, 2002·Science·Michael J O'ConnellRichard E Smalley
Oct 3, 2002·Journal of the American Chemical Society·David T MitchellCharles R Martin
Dec 3, 2002·Science·Sergei M BachiloR Bruce Weisman
Dec 18, 2002·Accounts of Chemical Research·Ya-Ping SunWeijie Huang
Jan 2, 2003·Nature Reviews. Drug Discovery·Charles R Martin, Punit Kohli
Jan 30, 2003·Journal of the American Chemical Society·Christopher A Dyke, James M Tour
Feb 7, 2003·Current Medicinal Chemistry·Sergey B Zotchev
May 6, 2003·Science·Cyrille RichardCharles Mioskowski
May 13, 2003·Clinical Pharmacokinetics·Alberto GabizonYechezkel Barenholz
May 24, 2003·Biochemical and Biophysical Research Communications·Norman I Krinsky, Kyung-Jin Yeum
Jul 10, 2003·Journal of the American Chemical Society·Michael HolzingerAndreas Hirsch
Jul 17, 2003·Journal of the American Chemical Society·Huijun Xin, Adam T Woolley
Dec 4, 2003·Bioorganic & Medicinal Chemistry Letters·Tadahiko MashinoMasataka Mochizuki
Jan 23, 2004·Chemical Communications : Chem Comm·Davide PantarottoAlberto Bianco
May 4, 2004·Human Immunology·Tjadine M HollingPeter J van Den Elsen
Jun 4, 2004·Journal of the American Chemical Society·Nadine Wong Shi KamHongjie Dai
Aug 3, 2004·Cancer Gene Therapy·Eugene Lin, John Nemunaitis
Aug 20, 2004·Occupational and Environmental Medicine·K DonaldsonP J A Borm
Sep 10, 2004·Journal of the American Chemical Society·Jared L HudsonJames M Tour
Sep 28, 2004·Physical Review Letters·T OhtsukiK Ohno
Sep 30, 2004·Angewandte Chemie·Davide PantarottoAlberto Bianco

❮ Previous
Next ❯

Citations

Mar 13, 2013·AAPS PharmSciTech·Naghmeh HadidiReza Aboofazeli
Dec 23, 2009·Nanomedicine·Vittoria RaffaAlfred Cuschieri
Mar 4, 2014·BioMed Research International·Giuseppe CirilloFrancesca Iemma
Sep 23, 2014·The Journal of Chemical Physics·Shu-Ching Ou, Sandeep Patel
Nov 29, 2014·Expert Opinion on Drug Delivery·Markus Martincic, Gerard Tobias
Jun 6, 2012·Expert Opinion on Drug Delivery·Sibel Ilbasmis-Tamer, Ismail Tuncer Degim
Feb 2, 2016·International Journal of Pharmaceutics·Muhammad Imran SajidAbdelhamid Elaissari
Jan 8, 2013·Journal of Molecular Graphics & Modelling·Chompoonut RungnimHisashi Okumura
Mar 25, 2016·The Journal of Membrane Biology·Khaoula BoukariFabien Picaud
May 23, 2015·Drug Discovery Today·Prashant KesharwaniNarendra Kumar Jain
Feb 11, 2015·Clinical Pharmacokinetics·Kamla Pathak, Smita Raghuvanshi
Aug 23, 2018·Advanced Materials·Kian Ping LohEdward Kai-Hua Chow
Feb 11, 2011·Chemistry : a European Journal·Cécilia Ménard-MoyonAlberto Bianco
Sep 4, 2015·Chemistry : a European Journal·Cécilia Ménard-MoyonAlberto Bianco
Jan 21, 2017·Oncology Letters·Xiao-Ying Zhang, Pei-Ying Zhang
Feb 13, 2012·Materials·D Lynn KirkpatrickOlga Gliko
Dec 15, 2012·Chemistry : a European Journal·Béatrice VanhorenbekeSophie Hermans
May 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Manuela CurcioGiuseppe Cirillo
Oct 27, 2011·Expert Review of Medical Devices·Chee Leng LayYe Liu
May 28, 2019·Journal of Computational Chemistry·Mohsen AbbaspourReyhaneh Ebrahimi
Jan 8, 2021·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Maria NicolettiElisa Fasoli
Dec 21, 2019·Nanomedicine : Nanotechnology, Biology, and Medicine·Leticia Santos PimentelPaula Cristina Batista de Faria
Jan 8, 2017·Biomaterials·Leoni A Kunz-SchughartSuman Pokhrel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.